[Edaily Starin Choi Hee-jae Reporter] Yuna of the group BB Girls is set to join this summer’s comeback battle with her refreshing visuals. BB Girls’ Yuna (Photo: GLG) On the 10th, B.B. Girls unveiled concept photos of Yuna for their new single “BODY WAVE” via their official social media accounts. In the released photos, Yuna exudes a healthy, vibrant charm while wearing a sporty blue and red rash guard. Her lively and energetic gaze as she stares into the camera instantly captures the viewer’s attention. In another photo, she changes the vibe, leaning back on a sunbed with a smile. Wearing bright, lace-style beachwear and a skirt, Yuna exudes an innocent charm while rocking her signature bob. BB Girls’ Yuna (Photo = GLG) With Yuna—the final member following Minyoung and Eunji—revealing her concept photos, the excitement for their comeback has heated up even further. Music fans are eagerly awaiting to see what refreshing music and performances B.B. Girls will bring to the K-pop scene this summer. BB Girls’ new single features a “summer song” produced specifically for the summer season. An agency representative stated, “BB Girls will kick off their promotional activities with a refreshing track that embodies their signature healthy and bright energy.” BB Girls have risen to prominence as the stars of a “reverse-charting” phenomenon, with songs like “Rollin’” and “We Ride” gaining renewed attention one after another. Since joining the global label GLG in 2024, they released the single “LOVE 2,” which was well-received by the public. They have continued their solid momentum by successfully wrapping up the release of a remake track and an official fan meeting. “Body Wave” will be released on the 16th at 6:00 p.m. via various online music platforms.
Fluctuations in credit spreads serve as an indicator of investor sentiment and capital flows in the corporate bond market. “Credit Signal” provides an intuitive analysis of the market’s overall trends…
SCL Science(246960)is accelerating its new drug development efforts, spearheaded by vaccines for liver and ovarian cancer. With the goal of submitting an Investigational New Drug (IND) application nex…
“Batoclimab,” a treatment for autoimmune diseases developed by HANALL BIOPHARMA CO.,LTD(009420), has received new drug approval in China. This comes approximately nine years after the company licensed…